130 related articles for article (PubMed ID: 12534223)
1. [Immunohistochemical examinations of dyskeratosis and exocervical neoplasia in gynecological pathology].
Frolova II; Mestergazi GM; Radzinskiĭ VE; Sheliastina NN; Babichenko II
Arkh Patol; 2002; 64(6):23-6. PubMed ID: 12534223
[TBL] [Abstract][Full Text] [Related]
2. Detection of p53 protein and Ki-67 proliferation antigen in human papillomavirus (HPV)-positive and HPV-negative cervical lesions by immunohistochemical double-staining.
Tervahauta AI; Syrjänen SM; Mäntyjärvi R; Syrjänen KJ
Cytopathology; 1994 Oct; 5(5):282-93. PubMed ID: 7819513
[TBL] [Abstract][Full Text] [Related]
3. Expression of Ki-67 and squamous intraepithelial lesions are related with HPV in endocervical adenocarcinoma.
Cambruzzi E; Zettler CG; Alexandre CO
Pathol Oncol Res; 2005; 11(2):114-20. PubMed ID: 15999157
[TBL] [Abstract][Full Text] [Related]
4. bcl-2 immunoreactivity, human papillomavirus DNA, and cervical intraepithelial neoplasia.
Cooper K; Haffajee Z; Taylor L
Mod Pathol; 1999 Jun; 12(6):612-7. PubMed ID: 10392638
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18.
Akasofu M; Oda Y
Virchows Arch; 1995; 425(6):593-602. PubMed ID: 7697216
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia.
Dellas A; Schultheiss E; Almendral AC; Gudat F; Oberholzer M; Feichter G; Moch H; Torhorst J
Int J Cancer; 1997 Aug; 74(4):421-5. PubMed ID: 9291432
[TBL] [Abstract][Full Text] [Related]
7. The association of vascular proliferation with HPV status and epithelial PCNA positivity in cervical intraepithelial lesions.
Soini Y; Pöllänen R; Kemppainen S; Pääkkö P; Lehto VP
APMIS; 1996 Mar; 104(3):183-90. PubMed ID: 8611192
[TBL] [Abstract][Full Text] [Related]
8. Flow Cytometry Characterization of Pluripotent Transmembrane Glycoproteins on Resident Cervix Uteri Cells in Patients Screened for Cervical Cancer.
Colacurci N; Schettino MT; Grimaldi V; De Luca FP; Mansueto G; Costa D; Cacciatore F; De Franciscis P; Napoli C
Cancer Invest; 2020 Apr; 38(4):228-239. PubMed ID: 32208057
[TBL] [Abstract][Full Text] [Related]
9. Negative predictive value of human papillomavirus test following conization of the cervix uteri.
Jain S; Tseng CJ; Horng SG; Soong YK; Pao CC
Gynecol Oncol; 2001 Jul; 82(1):177-80. PubMed ID: 11426982
[TBL] [Abstract][Full Text] [Related]
10. The possible role of bcl-2 expression in the progression of tumors of the uterine cervix.
Saegusa M; Takano Y; Hashimura M; Shoji Y; Okayasu I
Cancer; 1995 Dec; 76(11):2297-303. PubMed ID: 8635035
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and morphologic aspects of cervical papillomavirus infection].
Kolomiets LA; Urazova LN; Sevost'ianova NV; Churuksaeva ON
Vopr Onkol; 2002; 48(1):43-6. PubMed ID: 12101564
[TBL] [Abstract][Full Text] [Related]
12. An immunohistochemical analysis of sex-steroid receptors, tumor suppressor gene p53 and Ki-67 in the normal and neoplastic uterine cervix squamous epithelium.
Nikolaou M; Koumoundourou D; Ravazoula P; Papadopoulou M; Michail G; Decavalas G
Med Pregl; 2014; 67(7-8):202-7. PubMed ID: 25151759
[TBL] [Abstract][Full Text] [Related]
13. Expression of cytokeratin polypeptides in human papillomavirus (HPV) lesions of the uterine cervix: 1. Relationship to grade of CIN and HPV type.
Syrjänen S; Cintorino M; Armellini D; Del Vecchio MT; Leoncini P; Bugnoli M; Pallini V; Silvestri S; Tosi P; Mäntyjärvi R
Int J Gynecol Pathol; 1988; 7(1):23-38. PubMed ID: 2450850
[TBL] [Abstract][Full Text] [Related]
14. Detection of human papillomaviruses (HPV-16,18) in cervical smears by in situ hybridization.
Marin J; Ursic-Vrscaj M; Erzen M
Isr J Med Sci; 1994; 30(5-6):448-50. PubMed ID: 8034501
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to human papillomavirus 16 and subsequent in situ or invasive cancer of the cervix.
Shah KV; Viscidi RP; Alberg AJ; Helzlsouer KJ; Comstock GW
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):233-7. PubMed ID: 9107427
[TBL] [Abstract][Full Text] [Related]
16. Cidofovir, a new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III).
Snoeck R; Noel JC; Muller C; De Clercq E; Bossens M
J Med Virol; 2000 Feb; 60(2):205-9. PubMed ID: 10596022
[TBL] [Abstract][Full Text] [Related]
17. p53 immunoreactivity in cervical intraepithelial neoplasia and non-neoplastic cervical squamous epithelium.
Jeffers MD; Richmond J; Farquharson M; McNicol AM
J Clin Pathol; 1994 Dec; 47(12):1073-6. PubMed ID: 7876377
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus infection of the uterine cervix: histological appearances in 28 cases identified by immunohistochemical techniques.
Dyson JL; Walker PG; Singer A
J Clin Pathol; 1984 Feb; 37(2):126-30. PubMed ID: 6319459
[TBL] [Abstract][Full Text] [Related]
19. Detection and typing of human papilloma virus DNAs in normal cervix, intraepithelial neoplasia and cervical cancer in Bangkok.
Siritantikorn S; Laiwejpithaya S; Siripanyaphinyo U; Auewarakul P; Yenchitsomanus P; Thakernpol K; Wasi C
Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):707-10. PubMed ID: 9656389
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of p53 and bcl-2 proteins in neoplastic and non-neoplastic endocervical glandular lesions.
McCluggage G; McBride H; Maxwell P; Bharucha H
Int J Gynecol Pathol; 1997 Jan; 16(1):22-7. PubMed ID: 8986528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
